强效和选择性的G蛋白结合受体激酶5抑制剂:设计,合成,评估和X射线结构研究
Arun K Ghosh1, Rajesh Manda2, Ranjith Kumar Gadi2
1Department of Chemistry, Purdue University, West Lafayette, IN, 47907, USA; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, 47907, USA.
研究人员使用基于结构的方法设计了强效的,选择性的G蛋白结合受体激酶5 (GRK5) 抑制剂. 这些新型化合物显示出开发心力衰竭和癌症新疗法的前景.
科学领域:
- 药用化学 医学化学
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- G蛋白结合受体激酶5 (GRK5) 是心力衰竭和癌症的重要治疗点.
- 现有的药物支架,如苏尼替尼,为开发新型激酶抑制剂提供了基础.
研究的目的:
- 设计和合成GRK5.5的新型,强效,选择性,非共价和类似药物的抑制剂.
- 利用基于结构的药物设计原则来优化抑制剂的有效性和选择性.
主要方法:
- 利用受苏尼蒂尼布启发的pyrroloindolinone支架,用于抑制剂设计.
- 采用基于结构的设计和药物化学方法来产生一系列GRK5抑制剂.
- 确定GRK5抑制剂复合物的高分辨率X射线晶体结构.
主要成果:
- 开发了一系列高度选择性和强大的非共价GRK5抑制剂.
- 实现了低纳米分子强度和高选择性对相关的激酶GRK2.
- 获得了三种X射线晶体结构,阐明了关键的带结合位点相互作用.
结论:
- 开发的GRK5抑制剂在心血管疾病和瘤学方面显示出显著的治疗潜力.
- 结构-活动关系研究和结构洞察力将指导进一步优化临床开发.
- 这些发现为基于GRK5抑制剂的新型疗法铺平了道路.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
相关概念视频
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
GPCR Desensitization
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
